Skip to main content
Erschienen in:

18.03.2021 | Original Scientific Report

The Added Value of Technetium-99 m Sestamibi Scan in Patients with Primary Hyperparathyroidism and Positive Ultrasound

verfasst von: T. Yalon, M. Neymark, A. Rottenberg, L. Appelbaum, D. Assaf, Y. Kluger, H. Mazeh, M. Mekel

Erschienen in: World Journal of Surgery | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Neck ultrasound (US) and Technetium-99 m Sestamibi (MIBI) scan are the most commonly used imaging studies for preoperative localization of parathyroid adenomas. The aim of this study was to determine the added value of MIBI scan and its effect on the operative plan via a hypothetical model where a stepwise approach is conducted and MIBI is considered only after the ultrasound is evaluated.

Methods

Patients who underwent parathyroidectomy for primary hyperparathyroidism (PHPT) between 2012 and 2019 at two tertiary centers were included. Data collected included demographic data, preoperative workup, operative findings and follow-up. The added value of MIBI scans was determined for patients with positive ultrasound.

Results

A total of 513 patients with positive US result and a MIBI scan were included. If a stepwise approach was conducted then MIBI scan would not change the operative plan in 492 (95.9%). Among the remaining 21 patients, MIBI scan would correctly change the ultrasound-based operative plan in only 12 (2.3%) patients, while incorrectly change the plan in 9 (1.8%), resulting in unnecessary exploration of the contralateral side. In patients with sonographic appearance of a parathyroid gland larger than 1.2 cm, MIBI scan would correctly change the operative plan in only 1 of the 287 (0.35%) patients.

Conclusions

Our study suggests that the routine use of MIBI scans may have limited added value in patients with PHPT and a positive neck ultrasound, especially in those with adenoma size larger than 1.2 cm. Positive ultrasound alone may be sufficient for the preoperative localization of parathyroid disease.
Literatur
1.
Zurück zum Zitat Press DM, Siperstein AE, Berber E et al (2013) The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154(6):1232–1238CrossRef Press DM, Siperstein AE, Berber E et al (2013) The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154(6):1232–1238CrossRef
2.
Zurück zum Zitat Bilezikian JP, Bandeira L, Khan A, Cusano NE (2018) Hyperparathyroidism. Lancet 391:168–178CrossRef Bilezikian JP, Bandeira L, Khan A, Cusano NE (2018) Hyperparathyroidism. Lancet 391:168–178CrossRef
3.
Zurück zum Zitat Wilhelm SM, Wang TS, Ruan DT et al (2017) The definitive management of primary hyperparathyroidism who needs an operation? JAMA - J Am Med Assoc 317(11):959–968 Wilhelm SM, Wang TS, Ruan DT et al (2017) The definitive management of primary hyperparathyroidism who needs an operation? JAMA - J Am Med Assoc 317(11):959–968
5.
Zurück zum Zitat Schneider DF, Mazeh H, Chen H, Sippel RS (2014) Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases. Ann Surg 259(3):563–568CrossRef Schneider DF, Mazeh H, Chen H, Sippel RS (2014) Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases. Ann Surg 259(3):563–568CrossRef
6.
Zurück zum Zitat Kuzminski SJ, Sosa JA, Hoang JK (2018) Update in parathyroid imaging. Magn Reson Imaging Clin N Am 26(1):151–166CrossRef Kuzminski SJ, Sosa JA, Hoang JK (2018) Update in parathyroid imaging. Magn Reson Imaging Clin N Am 26(1):151–166CrossRef
7.
Zurück zum Zitat Zafereo M, Yu J, Angelos P et al (2019) American head and neck society endocrine surgery section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck 41(7):2398–2409CrossRef Zafereo M, Yu J, Angelos P et al (2019) American head and neck society endocrine surgery section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck 41(7):2398–2409CrossRef
8.
Zurück zum Zitat Bilezikian JP, Khan AA, Potts JT (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94(2):335–339CrossRef Bilezikian JP, Khan AA, Potts JT (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94(2):335–339CrossRef
9.
Zurück zum Zitat Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99(10):3561–3569CrossRef Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99(10):3561–3569CrossRef
10.
Zurück zum Zitat Doppman J (1986) No title. Reoperative Parathyr Surg localization Proced 18:117–132 Doppman J (1986) No title. Reoperative Parathyr Surg localization Proced 18:117–132
11.
Zurück zum Zitat Frank E, Watson WA, Fujimoto S, De Andrade FP, Inman J, Simental A (2020) Surgery versus imaging in non-localizing primary hyperparathyroidism: a cost-effectiveness model. Laryngoscope 130(12):E963–E969CrossRef Frank E, Watson WA, Fujimoto S, De Andrade FP, Inman J, Simental A (2020) Surgery versus imaging in non-localizing primary hyperparathyroidism: a cost-effectiveness model. Laryngoscope 130(12):E963–E969CrossRef
13.
Zurück zum Zitat Moghadam RN, Amlelshahbaz AP, Namiranian N et al (2017) Comparative diagnostic performance of ultrasonography and 99mTc-Sestamibi scintigraphy for parathyroid adenoma in primary hyperparathyroidism; systematic review and meta-analysis. Asian Pacific J Cancer Prev 18(12):3195–3200 Moghadam RN, Amlelshahbaz AP, Namiranian N et al (2017) Comparative diagnostic performance of ultrasonography and 99mTc-Sestamibi scintigraphy for parathyroid adenoma in primary hyperparathyroidism; systematic review and meta-analysis. Asian Pacific J Cancer Prev 18(12):3195–3200
14.
Zurück zum Zitat Al-kurd A, Levit B, Assaly M, Mizrahi I (2018) Preoperative localization modalities in primary hyperparathyroidism: correlation with postoperative cure. Surgery 164(1):1–7CrossRef Al-kurd A, Levit B, Assaly M, Mizrahi I (2018) Preoperative localization modalities in primary hyperparathyroidism: correlation with postoperative cure. Surgery 164(1):1–7CrossRef
15.
Zurück zum Zitat Ebner Y, Garti-gross Y, Margulis A, Levy Y, Nabrisky D, Ophir D (2015) Parathyroid surgery: correlation between pre-operative localization studies and surgical outcome. Clin Endocrinol 83(5):733–738CrossRef Ebner Y, Garti-gross Y, Margulis A, Levy Y, Nabrisky D, Ophir D (2015) Parathyroid surgery: correlation between pre-operative localization studies and surgical outcome. Clin Endocrinol 83(5):733–738CrossRef
16.
Zurück zum Zitat Korwar V, Yuen Chang F, Teasdale E, Suchett-Kaye I, Edwards A, Morgan J (2020) Stepwise approach for parathyroid localisation in primary hyperparathyroidism. World J Surg 44(3):803–809CrossRef Korwar V, Yuen Chang F, Teasdale E, Suchett-Kaye I, Edwards A, Morgan J (2020) Stepwise approach for parathyroid localisation in primary hyperparathyroidism. World J Surg 44(3):803–809CrossRef
Metadaten
Titel
The Added Value of Technetium-99 m Sestamibi Scan in Patients with Primary Hyperparathyroidism and Positive Ultrasound
verfasst von
T. Yalon
M. Neymark
A. Rottenberg
L. Appelbaum
D. Assaf
Y. Kluger
H. Mazeh
M. Mekel
Publikationsdatum
18.03.2021
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 7/2021
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-021-06066-8

Neu im Fachgebiet Chirurgie

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Kein Unterschied bei inadäquaten Schocks zwischen ICD-Typen

Inadäquate Schockabgaben sind ein unerwünschter Effekt der Therapie mit implantierbaren Kardioverter-Defibrillatoren. Subkutanen Geräten haftet dabei der Ruf an, dafür besonders anfällig zu sein. Die PRAETORIAN-Forschungsgruppe ist dem nachgegangen.

DCIS: Ist ein Verzicht auf eine Operation möglich?

Die COMET-Studie zeigt, dass aktives Monitoring bei Patientinnen mit duktalem Carcinoma in situ (DCIS) hinsichtlich der kumulativen Zwei-Jahres-Rate an ipsilateralen invasiven Karzinomen der leitliniengerechten Standardbehandlung nicht unterlegen ist. Dennoch wird von einem Verzicht auf eine Operation abgeraten, wie in einem begleitenden Editorial betont wird.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.